Stay updated on Apremilast in Nummular Eczema Clinical Trial
Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error page with the site header and footer, indicating access is blocked rather than showing the study details.SummaryDifference19%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, representing a small update to the study record metadata rather than substantive changes to the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, with no visible changes to the study details or page structure.SummaryDifference0.1%

- Check59 days agoChange DetectedA new Publications entry citing Bohner A. et al. about the apremilast/nummular eczema study is added, with a PubMed note; the page revision is updated to v3.6.4, replacing the prior v3.6.3 entry.SummaryDifference0.3%

- Check80 days agoChange DetectedA new revision tag (v3.6.3) has been added, replacing the previous revision (v3.6.2). This indicates a minor update to the page without changing the study information.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now shows revision v3.6.2, replacing v3.6.0, indicating a minor update to the page template or data. The update does not alter study details, eligibility criteria, or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.